Research Assistant Professor
Yan Gong, Ph.D., is a Research Assistant Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and the UF Center for Pharmacogenomics. Dr. Gong received a Ph.D. in Pharmaceutics in 2004 from Department of Pharmaceutics, College of Pharmacy at UF. She also obtained a Masterís Degree in Statistics in 2003 from UF Department of Statistics. Before joining the UF faculty in 2005, she completed one year of post-doctoral fellowship in Cardiovascular Pharmacogenomics at the UF Center for Pharmacogenomics under Dr. Julie Johnsonís mentorship. Her trainings gave her a background in biostatistics, statistical genetics, gene therapy and the pharmaceutical sciences.
Dr. Gong's research focuses on cardiovascular drug pharmacogenomics and disease-gene association that may be relevant to pharmacogenomics, and the influence of ethnicity on pharmacogenomics. She specializes in analysis for Pharmacogenomics associations in experimental and observational studies including genome-wide association studies (GWAS). The majority of her research centers around hypertension and cardiovascular adverse outcomes, with a focus on proteins/genes that are drug targets and receptors and their impact on disease and drug response. Dr. Gong is the lead statistical geneticist for INternational VERapamil SR-Trandolapril Study (INVEST) and the Genetic Substudy (INVEST-GENEs). She is also a co-investigator for Pharmacogenetic Evaluation of Antihypertensives Responses (PEAR) and an active member of the NIH Pharmacogenetics Research Network (PGRN).
Dr. Gong is also collaborating with investigators in College of Dentistry, College of Medicine and the Malcom Randall VA Medical Center on the Pharmacogenomics related to adverse drug reaction related to bisphosphonates: bisphosphonate-associated osteonecrosis of the jaw (BONJ).